Advanced Search
Molecules
Pines, M., Volcani Center, Institute of Animal Science, P.O. Box 6, Bet Dagan, Israel
Spector, I., Volcani Center, Institute of Animal Science, P.O. Box 6, Bet Dagan, Israel, Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel
Halofuginone is an analog of febrifugine-an alkaloid originally isolated from the plant Dichroa febrifuga. During recent years, halofuginone has attracted much attention because of its wide range of beneficial biological activities, which encompass malaria, cancer, and fibrosis-related and autoimmune diseases. At present two modes of halofuginone actions have been described: (1) Inhibition of Smad3 phosphorylation downstream of the TGFβ signaling pathway results in inhibition of fibroblasts-to-myofibroblasts transition and fibrosis. (2) Inhibition of prolyl-tRNA synthetase (ProRS) activity in the blood stage of malaria and inhibition of Th17 cell differentiation thereby inhibiting inflammation and the autoimmune reaction by activation of the amino acid starvation and integrated stress responses. This review deals with the history and origin of this natural product, its synthesis, its known modes of action, and it's various biological activities in pre-clinical animal models and in humans. © 2015 by the authors licensee MDPI Basel Switzerland.
Powered by ClearMash Solutions Ltd -
Volcani treasures
About
Terms of use
Halofuginone - The multifaceted molecule
20
Pines, M., Volcani Center, Institute of Animal Science, P.O. Box 6, Bet Dagan, Israel
Spector, I., Volcani Center, Institute of Animal Science, P.O. Box 6, Bet Dagan, Israel, Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel
Halofuginone - The multifaceted molecule
Halofuginone is an analog of febrifugine-an alkaloid originally isolated from the plant Dichroa febrifuga. During recent years, halofuginone has attracted much attention because of its wide range of beneficial biological activities, which encompass malaria, cancer, and fibrosis-related and autoimmune diseases. At present two modes of halofuginone actions have been described: (1) Inhibition of Smad3 phosphorylation downstream of the TGFβ signaling pathway results in inhibition of fibroblasts-to-myofibroblasts transition and fibrosis. (2) Inhibition of prolyl-tRNA synthetase (ProRS) activity in the blood stage of malaria and inhibition of Th17 cell differentiation thereby inhibiting inflammation and the autoimmune reaction by activation of the amino acid starvation and integrated stress responses. This review deals with the history and origin of this natural product, its synthesis, its known modes of action, and it's various biological activities in pre-clinical animal models and in humans. © 2015 by the authors licensee MDPI Basel Switzerland.
Scientific Publication
You may also be interested in